Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer female

Not yet recruiting

Registered drugNo placebo

Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Breast cancer

Not yet recruiting

Registered drugNo placebo

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Migraine

Not recruiting

Investigational

Study of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Clostridium Botulinum, Neurotoxin Serotype A/B

Contact Research Centre

Psoriasis

Not recruiting

Registered drug

Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Apremilast

Contact Research Centre

Psoriasis

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Zasocitinib

Contact Research Centre

Dermatitis atopic

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nemolizumab

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Sonelokimab

Contact Research Centre

Dementia Alzheimer's type

Not recruiting

Investigational

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Quinidine Sulfate

Contact Research Centre

Parkinson's disease

Not recruiting

InvestigationalNo placebo

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Tavapadon

Contact Research Centre

Ischaemic stroke+2

Not recruiting

Investigational

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Asundexian

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Amlitelimab

Contact Research Centre

Parkinson's disease

Not recruiting

Registered drugNo placebo

Comparing Skin Adhesiveness of a New Rotigotine 12 mg/24 h Transdermal Patch Versus Standard Treatment in Patients with Parkinson's Disease

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Rotigotine

Contact Research Centre

Find therapies in clinical trials near you – page 3

55 trials match your criteria

Breast cancer female

Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer

Breast cancer

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Migraine

Study of IPN10200 compared to placebo for prevention of episodic or chronic migraine in adults

Psoriasis

Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

Psoriasis

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Dermatitis atopic

Study on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Hidradenitis

Study on the Effects of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

Dementia Alzheimer's type

Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients

Parkinson's disease

Study on the Long-Term Safety of Tavapadon for Patients with Parkinson's Disease

Ischaemic stroke+2

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Dermatitis atopic

Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

Parkinson's disease

Comparing Skin Adhesiveness of a New Rotigotine 12 mg/24 h Transdermal Patch Versus Standard Treatment in Patients with Parkinson's Disease

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.